Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Expert Rev Vaccines ; 20(9): 1177-1183, 2021 09.
Article in English | MEDLINE | ID: covidwho-1338598

ABSTRACT

BACKGROUND: It remains hesitant to include a two-dose varicella vaccine (VarV) in a national routine immunization program in China. We aimed to quantify the impact of the two-dose VarV on varicella incidence in Shanghai. RESEARCH DESIGN AND METHODS: We directly extracted the data of varicella cases and VarV doses in 2013-2020 in Shanghai, and then estimated the effects of two-dose VarV using a Serfling model. RESULTS: A two-dose VarV immunization program has been extensively implemented since October 2017 and become free since August 2018 in Shanghai. Before and after this program, varicella cases significantly declined in children (P < 0.01), whereas did not in adults aged >18 years (P = 0.22). Compared to the predicted number of varicella cases, actual number was significantly lower by 8% in 2018 and 28% in 2019. Among children aged 4-6 years, the reduction in varicella cases was largest. Moreover, there was a significant reduction in varicella cases throughout 2020 (P < 0.001), in which the decrease due to social distancing for the COVID-19 was 54%. CONCLUSIONS: A two-dose VarV immunization program may further reduce approximately one-third of varicella cases in Shanghai. Children <4 years and adults benefit less in this program, which warrants enhancing the immunization.


Subject(s)
Chickenpox Vaccine/immunology , Chickenpox/epidemiology , Chickenpox/prevention & control , Mass Vaccination/statistics & numerical data , Vaccination/statistics & numerical data , COVID-19/prevention & control , Chickenpox Vaccine/administration & dosage , Child , Child, Preschool , China/epidemiology , Humans , Immunization Programs/statistics & numerical data , Physical Distancing
2.
MMWR Morb Mortal Wkly Rep ; 70(3): 75-82, 2021 01 22.
Article in English | MEDLINE | ID: covidwho-1040191

ABSTRACT

State and local school vaccination requirements serve to protect students against vaccine-preventable diseases (1). This report summarizes data collected by state and local immunization programs* on vaccination coverage among children in kindergarten (kindergartners) in 48 states, exemptions for kindergartners in 49 states, and provisional enrollment and grace period status for kindergartners in 28 states for the 2019-20 school year, which was more than halfway completed when most schools moved to virtual learning in the spring because of the coronavirus 2019 (COVID-19) pandemic. Nationally, vaccination coverage† was 94.9% for the state-required number of doses of diphtheria and tetanus toxoids, and acellular pertussis vaccine (DTaP); 95.2% for 2 doses of measles, mumps, and rubella vaccine (MMR); and 94.8% for the state-required number of varicella vaccine doses. Although 2.5% of kindergartners had an exemption from at least one vaccine,§ another 2.3% were not up to date for MMR and did not have a vaccine exemption. Schools and immunization programs can work together to ensure that undervaccinated students are caught up on vaccinations in preparation for returning to in-person learning. This follow-up is especially important in the current school year, in which undervaccination is likely higher because of disruptions in vaccination during the ongoing COVID-19 pandemic (2-4).


Subject(s)
Chickenpox Vaccine/administration & dosage , Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage , Measles-Mumps-Rubella Vaccine/administration & dosage , Vaccination Coverage/statistics & numerical data , Child , Child, Preschool , Humans , Immunization Schedule , United States , Vaccination/legislation & jurisprudence
SELECTION OF CITATIONS
SEARCH DETAIL